Cili Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cili Zhou has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Huangan Wu
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
5 shared publications Huirong Liu
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
5 shared publicationsLuyi Wu
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
3 shared publications- Chunhui Bao
Shanghai Clinical Research Centre for Acupuncture and Moxibustion, Yueyang Hospital of Integrated Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
2 shared publications - Huirong Liu
Shanghai Research Institute of Acupuncture and Meridian, Shanghai 200030, China
2 shared publications Jimeng Zhao
2 shared publications
Latest Publications
- 21 June 2025
- Published by Springer Nature in Journal of Acupuncture and Tuina Science
- Vol. 23 (3) , 197-209
Effects of moxibustion at Tianshu (ST25) and Qihai (CV6) on ACE/Ang II /AT1R axis in the colon tissue of Crohn disease mice with intestinal fibrosis
- 21 June 2025
- Published by Springer Nature in Journal of Acupuncture and Tuina Science
- Vol. 23 (3) , 197-209
Effects of moxibustion at Tianshu (ST25) and Qihai (CV6) on ACE/Ang II /AT1R axis in the colon tissue of Crohn disease mice with intestinal fibrosis
- 22 February 2025
- Published by Springer Nature in Journal of Acupuncture and Tuina Science
- Vol. 23 (2) , 135-143
Observation of the clinical efficacy of moxa-stick moxibustion in treating diarrhea-predominant irritable bowel syndrome
- 22 February 2025
- Published by Springer Nature in Journal of Acupuncture and Tuina Science
- Vol. 23 (2) , 135-143
Observation of the clinical efficacy of moxa-stick moxibustion in treating diarrhea-predominant irritable bowel syndrome
- Open Access
- 27 April 2023
- Published by Springer Nature in Journal of Acupuncture and Tuina Science
- Vol. 21 (2) , 91-100
Effects of moxibustion on behaviors and tryptophan metabolism-related products in mice with irritable bowel syndrome
Objective: To observe the effect of moxibustion on behaviors and related products of tryptophan (Trp) metabolism in the colon of mice with irritable bowel syndrome (IBS), and to explore the mechanism of moxibustion in the IBS treatment. Methods: Twenty-four mice were randomly divided into a normal group, a model group, a moxibustion group, and a probiotic group, with 6 mice in each group. The visceral pain model of IBS was established by enema with 2,4,6-trinitrobenzene sulfonic acid (TNBS) solution. Mice in the moxibustion group were treated with mild moxibustion at bilateral Zusanli (ST36), and those in the probiotic group were treated with probiotics such as Bifidobacterium by gavage. Abdominal withdrawal reflex (AWR) test, elevated plus-maze (EPM) test, and forced swimming test (FST) were performed after treatment. The expression levels of 5-hydroxytryptamine (5-HT) and tryptophan hydroxylase 1 (TPH1) in the colon were detected by immunofluorescence, and the expression levels of Trp, kynurenine (Kyn), and indole-2,3-oxygenase (IDO) in the colon were detected by enzyme-linked immunosorbent assay. Results: Compared with the normal group, the AWR scores were increased significantly in the model group under different pressure values (PPPPPPPPPPPPP<0.01). Conclusion: Moxibustion at Zusanli (ST36) improves visceral pain and pain mood and down-regulates the expression levels of colonic TPH1, IDO, Trp, 5-HT, and Kyn in IBS mice.
- 27 April 2023
- Published by Springer Nature in Journal of Acupuncture and Tuina Science
- Vol. 21 (2) , 91-100
Open AccessEffects of moxibustion on behaviors and tryptophan metabolism-related products in mice with irritable bowel syndrome
Objective: To observe the effect of moxibustion on behaviors and related products of tryptophan (Trp) metabolism in the colon of mice with irritable bowel syndrome (IBS), and to explore the mechanism of moxibustion in the IBS treatment. Methods: Twenty-four mice were randomly divided into a normal group, a model group, a moxibustion group, and a probiotic group, with 6 mice in each group. The visceral pain model of IBS was established by enema with 2,4,6-trinitrobenzene sulfonic acid (TNBS) solution. Mice in the moxibustion group were treated with mild moxibustion at bilateral Zusanli (ST36), and those in the probiotic group were treated with probiotics such as Bifidobacterium by gavage. Abdominal withdrawal reflex (AWR) test, elevated plus-maze (EPM) test, and forced swimming test (FST) were performed after treatment. The expression levels of 5-hydroxytryptamine (5-HT) and tryptophan hydroxylase 1 (TPH1) in the colon were detected by immunofluorescence, and the expression levels of Trp, kynurenine (Kyn), and indole-2,3-oxygenase (IDO) in the colon were detected by enzyme-linked immunosorbent assay. Results: Compared with the normal group, the AWR scores were increased significantly in the model group under different pressure values (PPPPPPPPPPPPP<0.01). Conclusion: Moxibustion at Zusanli (ST36) improves visceral pain and pain mood and down-regulates the expression levels of colonic TPH1, IDO, Trp, 5-HT, and Kyn in IBS mice.
- Open Access
- 31 January 2022
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 289, 115064
Mild moxibustion for Irritable Bowel Syndrome with Diarrhea (IBS-D): A randomized controlled trial
- 31 January 2022
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 289, 115064
Open AccessMild moxibustion for Irritable Bowel Syndrome with Diarrhea (IBS-D): A randomized controlled trial
- Open Access
- 28 October 2018
- Published by Baishideng Publishing Group Inc. in World Chinese Journal of Digestology
- Vol. 26 (30) , 1772-1777
Etiology related irritable bowel syndrome animal models
肠易激综合征(irritable bowel syndrome, IBS)属于慢性功能性肠道疾病, 其发病率在全球范围内呈逐年上升趋势. 目前病因和发病机制尚不完全明确, 较为公认的病因包括内脏高敏感、肠道感染、精神心理、胃肠激素、肠道菌群紊乱、基因遗传等因素. 因此, 研究者研发了多种与IBS病因相关的动物模型, 取得了重大研究进展并普遍应用于基础实验研究. 本文概括总结了目前与IBS病因相关的国内外通用的动物模型的制作方法, 以期为IBS基础研究的动物模型选择提供参考.
- 28 October 2018
- Published by Baishideng Publishing Group Inc. in World Chinese Journal of Digestology
- Vol. 26 (30) , 1772-1777
Open AccessEtiology related irritable bowel syndrome animal models
肠易激综合征(irritable bowel syndrome, IBS)属于慢性功能性肠道疾病, 其发病率在全球范围内呈逐年上升趋势. 目前病因和发病机制尚不完全明确, 较为公认的病因包括内脏高敏感、肠道感染、精神心理、胃肠激素、肠道菌群紊乱、基因遗传等因素. 因此, 研究者研发了多种与IBS病因相关的动物模型, 取得了重大研究进展并普遍应用于基础实验研究. 本文概括总结了目前与IBS病因相关的国内外通用的动物模型的制作方法, 以期为IBS基础研究的动物模型选择提供参考.
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S572
Su1859 Alterations in microRNA Expression Profiles in Inflamed and Non-Inflamed Ascending Colon Mucosae of Adult Patients With Active Crohn's Disease
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S572
Su1859 Alterations in microRNA Expression Profiles in Inflamed and Non-Inflamed Ascending Colon Mucosae of Adult Patients With Active Crohn's Disease
- Open Access
- 16 December 2014
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 14 (1) , 500
Brain regions involved in moxibustion-induced analgesia in irritable bowel syndrome with diarrhea: a functional magnetic resonance imaging study
Moxibustion is one of the most commonly used therapies in acupuncture practice, and is demonstrated to be beneficial for patients with diarrhea from irritable bowel syndrome (D-IBS). But its mechanism remains unclear. Because visceral hypersensitivity in IBS patients has been documented by evaluation of perceived stimulations through functional magnetic resonance imaging (fMRI) studies, we focused on observing brain imaging changes in D-IBS patients during rectal balloon distention before and after moxibustion in order to reveal its possible central mechanism and further evaluate its effect. This clinical trial is registered under the number: ChiCTR-TRC-10000887. Eighty D-IBS patients were randomly divided into a moxibustion and sham moxibustion group (control group) for a 4-week treatment. Fifteen patients in moxibustion group and thirteen patients in control group completed two fMRI scans during a 50 and 100 ml rectal balloon distention before and after treatment. Rectal pain were obtained with a scan test. Birmingham IBS Symptom Scale and IBS Quality of Life (QOL) Scale were used to evaluate therapeutic effect. After treatment, the decrease in Birmingham IBS Symptom Scale and IBS QOL Scale scores in moxibustion group was significantly greater than that of control group (P < 0.01). The defecation urge threshold and the pain perception threshold of moxibustion group was also significantly higher after treatment than that of control group (P < 0.01). The decrease in pain score during the 100 ml rectal balloon distention in moxibustion group was significantly greater than that of control group (P < 0.05). There was no definite activated center during the 50 ml rectal distention in either group before treatment. After treatment, the prefrontal cortex (PFC) was affected in moxibustion group, while the PFC and the anterior cingulated cortex (ACC) were affected in control group. During the 100 ml distention before treatment in both groups, the PFC and ACC were activated. After treatment, they disappeared in moxibustion group but remained in control group. Moxibustion can improve symptoms and quality of life in D-IBS patients. It can also decrease rectal sensitivity. The activation of PFC and ACC during a 100 ml rectal distention disappeared after moxibustion treatment.
- 16 December 2014
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 14 (1) , 500
Open AccessBrain regions involved in moxibustion-induced analgesia in irritable bowel syndrome with diarrhea: a functional magnetic resonance imaging study
Moxibustion is one of the most commonly used therapies in acupuncture practice, and is demonstrated to be beneficial for patients with diarrhea from irritable bowel syndrome (D-IBS). But its mechanism remains unclear. Because visceral hypersensitivity in IBS patients has been documented by evaluation of perceived stimulations through functional magnetic resonance imaging (fMRI) studies, we focused on observing brain imaging changes in D-IBS patients during rectal balloon distention before and after moxibustion in order to reveal its possible central mechanism and further evaluate its effect. This clinical trial is registered under the number: ChiCTR-TRC-10000887. Eighty D-IBS patients were randomly divided into a moxibustion and sham moxibustion group (control group) for a 4-week treatment. Fifteen patients in moxibustion group and thirteen patients in control group completed two fMRI scans during a 50 and 100 ml rectal balloon distention before and after treatment. Rectal pain were obtained with a scan test. Birmingham IBS Symptom Scale and IBS Quality of Life (QOL) Scale were used to evaluate therapeutic effect. After treatment, the decrease in Birmingham IBS Symptom Scale and IBS QOL Scale scores in moxibustion group was significantly greater than that of control group (P < 0.01). The defecation urge threshold and the pain perception threshold of moxibustion group was also significantly higher after treatment than that of control group (P < 0.01). The decrease in pain score during the 100 ml rectal balloon distention in moxibustion group was significantly greater than that of control group (P < 0.05). There was no definite activated center during the 50 ml rectal distention in either group before treatment. After treatment, the prefrontal cortex (PFC) was affected in moxibustion group, while the PFC and the anterior cingulated cortex (ACC) were affected in control group. During the 100 ml distention before treatment in both groups, the PFC and ACC were activated. After treatment, they disappeared in moxibustion group but remained in control group. Moxibustion can improve symptoms and quality of life in D-IBS patients. It can also decrease rectal sensitivity. The activation of PFC and ACC during a 100 ml rectal distention disappeared after moxibustion treatment.
- Open Access
- 1 January 2014
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2014 (1) , 895914
Mechanisms Underlying the Analgesic Effect of Moxibustion on Visceral Pain in Irritable Bowel Syndrome: A Review
Irritable bowel syndrome (IBS) is a functional bowel disorder that causes recurrent abdominal (visceral) pain. Epidemiological data show that the incidence rate of IBS is as high as 25%. Most of the medications may lead to tolerance, addiction and toxic side effects. Moxibustion is an important component of traditional Chinese medicine and has been used to treat IBS‐like abdominal pain for several thousand years in China. As a mild treatment, moxibustion has been widely applied in clinical treatment of visceral pain in IBS. In recent years, it has played an irreplaceable role in alternative medicine. Extensive clinical studies have demonstrated that moxibustion for treatment of visceral pain is simple, convenient, and inexpensive, and it is being accepted by an increasing number of patients. There have not been many studies investigating the analgesic mechanisms of moxibustion. Studies exploring the analgesic mechanisms have mainly focused on visceral hypersensitivity, brain‐gut axis neuroendocrine system, and immune system. This paper reviews the latest developments in moxibustion use for treatment of visceral pain in IBS from these perspectives. It also evaluates potential problems in relevant studies on the mechanisms of moxibustion therapy to promote the application of moxibustion in the treatment of IBS.
- 1 January 2014
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2014 (1) , 895914
Open AccessMechanisms Underlying the Analgesic Effect of Moxibustion on Visceral Pain in Irritable Bowel Syndrome: A Review
Irritable bowel syndrome (IBS) is a functional bowel disorder that causes recurrent abdominal (visceral) pain. Epidemiological data show that the incidence rate of IBS is as high as 25%. Most of the medications may lead to tolerance, addiction and toxic side effects. Moxibustion is an important component of traditional Chinese medicine and has been used to treat IBS‐like abdominal pain for several thousand years in China. As a mild treatment, moxibustion has been widely applied in clinical treatment of visceral pain in IBS. In recent years, it has played an irreplaceable role in alternative medicine. Extensive clinical studies have demonstrated that moxibustion for treatment of visceral pain is simple, convenient, and inexpensive, and it is being accepted by an increasing number of patients. There have not been many studies investigating the analgesic mechanisms of moxibustion. Studies exploring the analgesic mechanisms have mainly focused on visceral hypersensitivity, brain‐gut axis neuroendocrine system, and immune system. This paper reviews the latest developments in moxibustion use for treatment of visceral pain in IBS from these perspectives. It also evaluates potential problems in relevant studies on the mechanisms of moxibustion therapy to promote the application of moxibustion in the treatment of IBS.